Regulatory Alerts

As required under the Massachusetts Pharmaceutical and Medical Device Code of Conduct Regulation (105 CMR 970.000), manufacturers must report certain

May 21, 2026 – State of Connecticut Regulatory Alert The option to upload reports is now available on the Connecticut

May 15, 2026 – State of Connecticut Regulatory Alert The state of Connecticut has issued a new Pharmaceutical Marketing Firm

April 1st, 2026 – Regulatory Reminder: Pharmaceutical Sales Representative Disclosure Log Due Disclosure Logs Due April 1st, 2026 Oregon requires

April 1st, 2026 – Regulatory Reminder: Pharmaceutical Sales Representative Disclosure Log Due Disclosure Logs Due April 1st, 2026 Oregon requires

March 5, 2026 – Regulatory Alert: FDA Issues Final Rule on NDC Format The rule takes effect on March 7, 2033 FDA’s

March 1, 2026 – Regulatory Reminder: Nevada Annual Pharmaceutical Sales Representative Reports Due Reports Due March 1, 2026 Nevada’s annual

Action Required by January 1 2026 Summary  This alert is provided for informational purposes only. This is not a change to

Action Required by January 15 Manufacturers with pharmaceutical sales representatives operating in Nevada are required to update representative registration annually

Notification Date: October 23, 2025 As part of QPharma’s ongoing commitment to supporting life sciences organizations, we are providing this